HC Wainwright Has Lowered Expectations for Acrivon Therapeutics (NASDAQ:ACRV) Stock Price
Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) had its target price decreased by equities research analysts at HC Wainwright from $22.00 to $19.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright also issued estimates for Acrivon Therapeutics’ FY2029 earnings at ($1.25) EPS. Several other […]
Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) had its target price decreased by equities research analysts at HC Wainwright from $22.00 to $19.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright also issued estimates for Acrivon Therapeutics’ FY2029 earnings at ($1.25) EPS. Several other […]
